Clinical Trial Update: Effect of L-Dihydroxyphenylserine (L-DOPS) on Falls in Patients With Neurogenic Orthostatic Hypotension (NOH) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating L-Dihydroxyphenylserine (L-DOPS) for reducing falls in patients with neurogenic orthostatic hypotension, Parkinson disease subset.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Falls
• Neurogenic Orthostatic Hypotension
• Parkinson Disease
• Parkinson Disease with Orthostatic Hypotension

Drugs mentioned

• L-Dihydroxyphenylserine (L-DOPS) (L-Dihydroxyphenylserine)

Snippet

Sponsor: St. Joseph's Hospital and Medical Center, Phoenix | Conditions: Parkinson Disease, Falls Patient | Phase 2 | Status: UNKNOWN